CytoDyn (CYDY) Liabilities and Shareholders Equity (2011 - 2026)
CytoDyn's Liabilities and Shareholders Equity came in at $13.97 million for fiscal Q4 2026 (quarter ended May 31, 2026), down 22.6% from $18.05 million a year earlier and down 24.5% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, CytoDyn's Liabilities and Shareholders Equity data covers 61 quarters.
- Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -36.2% (FY2021 to FY2026).
- Going back by fiscal year, Liabilities and Shareholders Equity was $18.05 million in FY2025 (+62.1%), $11.14 million in FY2024 (-1.4%), $11.29 million in FY2023 (-61.3%) and $29.19 million in FY2022 (-77.9%).
- The five-year range for quarterly Liabilities and Shareholders Equity is $7.07 million (fiscal Q2 2023) to $104.97 million (fiscal Q1 2022).
- Year-over-year, Liabilities and Shareholders Equity has declined for four consecutive quarters, with growth averaging 39.0% over the last eight quarters.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in fiscal Q2 2025 (growth of 169.2%), and the weakest in fiscal Q2 2023 (a decline of 93.2%).
- Business Quant data shows CYDY's Liabilities and Shareholders Equity at $18.5 million (Q3 2026), $8.94 million (Q2 2026) and $13.48 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | CytoDyn | 274.70 Mn | 274.70 Mn | - | 13.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 13.97 Mn |
| Feb 28, 2026 | 18.50 Mn |
| Nov 30, 2025 | 8.94 Mn |
| Aug 31, 2025 | 13.48 Mn |
| May 31, 2025 | 18.05 Mn |
| Feb 28, 2025 | 21.19 Mn |
| Nov 30, 2024 | 24.88 Mn |
| Aug 31, 2024 | 28.02 Mn |
| May 31, 2024 | 11.14 Mn |
| Feb 29, 2024 | 10.27 Mn |
| Nov 30, 2023 | 9.24 Mn |
| Aug 31, 2023 | 12.41 Mn |
| May 31, 2023 | 11.29 Mn |
| Feb 28, 2023 | 14.64 Mn |
| Nov 30, 2022 | 7.07 Mn |
| Aug 31, 2022 | 28.39 Mn |
| May 31, 2022 | 29.19 Mn |
| Feb 28, 2022 | 94.08 Mn |
| Nov 30, 2021 | 103.70 Mn |
| Aug 31, 2021 | 104.97 Mn |
API Access
CytoDyn Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();